Results 231 to 240 of about 119,560 (316)

Do process evaluations open up the 'black box' of implementation interventions in health care? A scoping review. [PDF]

open access: yesImplement Sci
Bracci EL   +6 more
europepmc   +1 more source

Effect of Negative Pressure Therapy on Skin Blood Flow Responses in Scar Tissue. [PDF]

open access: yesCureus
Shen WC   +8 more
europepmc   +1 more source

Structure‐Guided Optimization and Biological Validation of 1,3,4‐Thiadiazole‐Based SIRT2 Inhibitors Reinforcing Channel Entrance Interactions

open access: yesDrug Development Research, Volume 87, Issue 2, April 2026.
ABSTRACT SIRT2, the cytoplasmic member of the sirtuin family, is generally acknowledged to promote cancer and contribute to the progression of various pathologies, including neurodegeneration, inflammation, obesity, and bacterial infection through the deacetylation of target substrates.
Ahmet Bugra Aksel   +9 more
wiley   +1 more source

Near-Peer Training: Impact of a Single Session on Students' OSCE Performance. [PDF]

open access: yesAdv Med Educ Pract
Alves AS   +5 more
europepmc   +1 more source

Pelanggaran Asas Good Faith terhadap Perjanjian Nuclear Non-Proliferation Treaty (NPT) Oleh Korea Utara

open access: hybrid
Syarifatul Fadhilah   +4 more
openalex   +2 more sources

Discovery of Capsazepine as a Novel MCL1 Inhibitor for Overcoming Tamoxifen Resistance in Breast Cancer Therapy

open access: yeseFood, Volume 7, Issue 2, April 2026.
MCL1 in promoting tamoxifen resistance by inhibiting apoptosis. This study demonstrates that the compound CPZ, identified through virtual screening and validated by molecular docking and experiments, directly binds to MCL1. This binding restores apoptosis and inhibits tumor growth, thereby combating resistance to endocrine therapy in breast cancer ...
Shujing Liu   +9 more
wiley   +1 more source

Small molecule NPT-440-1 inhibits ionic flux through Aβ 1-42 pores: Implications for Alzheimer's disease therapeutics

open access: green, 2016
Alan L. Gillman   +7 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy